Status:
UNKNOWN
The Role of Clinical Pharmacist in Management of DDIs in CHF Patients
Lead Sponsor:
The University Clinic of Pulmonary and Allergic Diseases Golnik
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
Phase:
NA
Brief Summary
Drug-drug interactions (DDIs) are common in patients with chronic heart failure (CHF) and their incidence increases with the number of drugs that the patients are prescribed for treatment of their con...
Eligibility Criteria
Inclusion
- Patients admitted with diagnosis of CHF I50.0 - I50.9 and I11.0 - I11.9 (ICD-10)
- patients treated with at least two drugs
Exclusion
- Patients admitted to other conditions
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01855165
Start Date
April 1 2013
End Date
December 1 2013
Last Update
May 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Golnik
Golnik, Slovenia, 4204